These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7850839)

  • 21. Drug-eluting stent: the "magic bullet" for prevention of restenosis?
    Hehrlein C; Arab A; Bode C
    Basic Res Cardiol; 2002 Nov; 97(6):417-23. PubMed ID: 12395203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concepts for local therapy of restenosis].
    Riessen R; Oberhoff M; Karsch KR
    Z Kardiol; 1996; 85 Suppl 1():87-98. PubMed ID: 8882829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local drug delivery for percutaneous coronary intervention.
    Sharma S; Christopoulos C; Kukreja N; Gorog DA
    Pharmacol Ther; 2011 Mar; 129(3):260-6. PubMed ID: 21111759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stent implantation in coronary arteries--current status].
    Frombach R; Schwartau M; Seger W
    Gesundheitswesen; 1997 Jul; 59(7):447-51. PubMed ID: 9333385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
    Kandzari DE; Tcheng JE; Zidar JP
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):562-76. PubMed ID: 12124974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The vascular stent in percutaneous coronary revascularization].
    Rozenman Y; Mosseri M; Lotan C; Gotsman MS
    Harefuah; 1994 Jun; 126(12):693-6, 764. PubMed ID: 7927009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery.
    Gradus-Pizlo I; Wilensky RL; March KL; Fineberg N; Michaels M; Sandusky GE; Hathaway DR
    J Am Coll Cardiol; 1995 Nov; 26(6):1549-57. PubMed ID: 7594084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravascular stents.
    Chapman GD; Gammon RS; Bauman RP; Stack RS
    Trends Cardiovasc Med; 1991 Apr; 1(3):127-31. PubMed ID: 21239328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracoronary stents: a new approach to coronary artery dilatation.
    Bevans M; McLimore E
    J Cardiovasc Nurs; 1992 Oct; 7(1):34-49. PubMed ID: 1447583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges.
    Bruck SD; Mueller EP
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):171-87. PubMed ID: 3060266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting bioresorbable stents for various applications.
    Zilberman M; Eberhart RC
    Annu Rev Biomed Eng; 2006; 8():153-80. PubMed ID: 16834554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioresorbable polymeric stents: current status and future promise.
    Eberhart RC; Su SH; Nguyen KT; Zilberman M; Tang L; Nelson KD; Frenkel P
    J Biomater Sci Polym Ed; 2003; 14(4):299-312. PubMed ID: 12747671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local drug delivery: an emerging approach in the treatment of restenosis.
    Ettenson DS; Edelman ER
    Vasc Med; 2000; 5(2):97-102. PubMed ID: 10943586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravascular stents.
    Lembo NJ; Roubin GS
    Cardiol Clin; 1989 Nov; 7(4):877-94. PubMed ID: 2688887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable and bioabsorbable stents.
    Waksman R; Pakala R
    Curr Pharm Des; 2010; 16(36):4041-51. PubMed ID: 21208182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.